Home
by admin

Aether Global Innovations Corp. Extends Acquisition Outside Date for Arion Defence Inc.

VANCOUVER, BC – August 4, 2026 – Leads & Copy – Aether Global Innovations Corp. (CSE: AETH) (OTC: AETHF) (Frankfurt: 4XA) (WKN# A2N8RH), a defense and security technology company, announced an amendment to its agreement to acquire Arion Defence Inc. The Amending Agreement, entered into among Aether Global Innovations Corp., 1401068 B.C. Ltd., and Arion Defence Inc., extends the outside date for the completion of the transaction to November 30, 2026, from the previous date of July 31, 2026. This extension provides the parties with additional time to finalize the acquisition of 100% of the issued and outstanding shares of Arion. All other terms and conditions of the original definitive agreement, dated April 1, 2026, remain unchanged.

Aether Global Innovations Corp. is a defense and security technology firm specializing in unmanned systems, counter-drone solutions, and advanced security scanning for critical infrastructure and high-value public and private sites. The company employs a disciplined platform model, which involves acquiring and partnering with established operators that possess existing revenue streams, intellectual property, and government relationships. Aether then aims to scale these assets through integration, capital deployment, and global distribution. By integrating counter-unmanned aerial vehicle capabilities, intelligence, surveillance, and reconnaissance (ISR)-oriented unmanned systems, and advanced screening technologies, Aether intends to offer mission-focused solutions designed for rapid deployment, enhancing customer safety, resilience, and operational awareness.

Further details regarding the transaction were initially announced in the Company’s news release dated April 2, 2026.

LeadsAndCopy

Share this story:

TwitterFacebookLinkedInEmail
×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.